Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-2-18
pubmed:abstractText
Recombinant viruses between the virulent Mahoney and attenuated Sabin 1 strains of poliovirus type 1 were subjected to neurovirulence tests using a transgenic (Tg) mouse line, ICR-PVRTg1, that carried the human poliovirus receptor gene. The Tg mice were inoculated intracerebrally with these recombinant viruses and observed for clinical signs, histopathological lesions, and viral antigens as parameters of neurovirulence of the viruses. These parameters observed in the Tg mice were different for different inoculated viruses. Dose-dependent incidences of paralysis and of death were observed in the Tg mice inoculated with any viruses used. This indicates that values of 50% lethal dose are useful to score a wide range of neurovirulence of poliovirus. The neurovirulence of individual viruses estimated by the Tg mouse model had a strong correlation with those estimated by monkey model. Consequently, the mouse tests identified the neurovirulence determinants on the genome of poliovirus that had been identified by monkey tests. In addition, the mouse tests revealed new neurovirulence determinants, that is, different nucleotides between the two strains at positions 189 and 21 and/or 935 in the 5'-proximal 1,122 nucleotides. The Tg mice used in this study may be suitable for replacing monkeys for investigating poliovirus neurovirulence.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-13097193, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-1370085, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-14778593, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-1707566, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-1846492, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-1846972, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-1847458, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2168976, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2170026, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2170108, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2536835, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2536836, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2536978, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2538245, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2547075, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2548171, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2552175, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2839704, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-2986004, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-3003384, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-3008430, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-3009852, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-3033275, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-3039178, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-6202874, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-6264310, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-6272282, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-6310508, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-6310545, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-6324200, http://linkedlifedata.com/resource/pubmed/commentcorrection/8289371-8390752
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
681-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8289371-Animals, pubmed-meshheading:8289371-Antigens, Viral, pubmed-meshheading:8289371-Central Nervous System, pubmed-meshheading:8289371-Disease Models, Animal, pubmed-meshheading:8289371-Female, pubmed-meshheading:8289371-Haplorhini, pubmed-meshheading:8289371-Immunohistochemistry, pubmed-meshheading:8289371-Lethal Dose 50, pubmed-meshheading:8289371-Male, pubmed-meshheading:8289371-Membrane Proteins, pubmed-meshheading:8289371-Mice, pubmed-meshheading:8289371-Mice, Transgenic, pubmed-meshheading:8289371-Phenotype, pubmed-meshheading:8289371-Poliomyelitis, pubmed-meshheading:8289371-Poliovirus, pubmed-meshheading:8289371-Poliovirus Vaccine, Oral, pubmed-meshheading:8289371-Receptors, Virus, pubmed-meshheading:8289371-Species Specificity, pubmed-meshheading:8289371-Virulence
pubmed:year
1994
pubmed:articleTitle
Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
pubmed:affiliation
Department of Microbiology, Tokyo Metropolitan Institute of Medical Science, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't